Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
It is unknown whether Zepbound (tirzepatide) causes thyroid C-cell tumors in humans
Regular monitoring is essential
Weight loss data what each Phase 3 trial actually showed In the TRIUMPH-4 Phase 3 trial (December 2025 readout, knee-osteoarthritis population), retatrutide at 12 mg produced approximately 28.7% body-weight reduction over 68 weeks using the efficacy estimand about 71 lbs of weight loss on average with 58.6% of participants reaching 25% weight loss
Liraglutide 3.0 mg (Saxenda) was approved for chronic weight management in December 2014 the first GLP-1 drug with an obesity indication
Downregulation of IGF-1 receptor occurs after hepatic linage commitment during hepatocyte differentiation from human embryonic stem cells
Talk to your provider about whether the generic liraglutide is appropriate for you
US$ 29.35
US$ 22.65
US$ 27.65
US$ 24.19
